Indeed, previously untreated FLT3-ITDhigh patients who received intensive chemotherapy with sorafenib, a FLT3 inhibitor, showed no significant but seemingly better relapse-free and overall survival than those with FLT3-ITDlow AML [34]. Here, FLT3 is linked to acute myeloid leukemia.